Concentrix [CNXC] vs Parsons [PSN] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Concentrix wins in 9 metrics, Parsons wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricConcentrixParsonsBetter
P/E Ratio (TTM)10.2239.23Concentrix
Price-to-Book Ratio0.693.71Concentrix
Debt-to-Equity Ratio111.1356.60Parsons
PEG Ratio0.02-1.96Parsons
EV/EBITDA5.2619.47Concentrix
Profit Margin (TTM)3.25%3.70%Parsons
Operating Margin (TTM)5.92%6.24%Parsons
EBITDA Margin (TTM)5.92%6.24%Parsons
Return on Equity7.43%12.44%Parsons
Return on Assets (TTM)3.85%4.96%Parsons
Free Cash Flow (TTM)$428.73M$474.39MParsons
Dividend Yield3.51%N/AN/A
1-Year Return-0.83%-17.49%Concentrix
Price-to-Sales Ratio (TTM)0.311.40Concentrix
Enterprise Value$7.48B$10.52BParsons
EV/Revenue Ratio0.771.57Concentrix
Gross Profit Margin (TTM)N/A21.99%N/A
Revenue per Share (TTM)$153$63Concentrix
Earnings per Share (Diluted)$4.72$2.23Concentrix
Beta (Stock Volatility)0.550.64Concentrix
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Concentrix vs Parsons Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Concentrix-1.49%-0.61%-9.52%-16.13%0.74%9.19%
Parsons0.97%7.89%17.77%18.82%50.02%-2.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Concentrix-0.83%-59.61%-40.58%-40.58%-40.58%-40.58%
Parsons-17.49%117.99%164.70%184.84%184.84%184.84%

News Based Sentiment: Concentrix vs Parsons

Concentrix

News based Sentiment: MIXED

Concentrix reported mixed Q3 results with a revenue beat but EPS and EBITDA misses, leading to lowered guidance. However, the company continues to invest in AI and return capital to shareholders, creating a complex investment narrative with both positive and negative elements.

View Concentrix News Sentiment Analysis

Parsons

News based Sentiment: MIXED

October was a mixed month for Parsons, marked by significant contract wins and a strategic acquisition that bolster long-term growth prospects, but tempered by expectations of a year-over-year earnings decline. The positive analyst sentiment and insider activity provide some reassurance, but the upcoming earnings report will be crucial for investors.

View Parsons News Sentiment Analysis

Performance & Financial Health Analysis: Concentrix vs Parsons

MetricCNXCPSN
Market Information
Market Cap i$3.10B$9.34B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,434,8801,034,329
90 Day Avg. Volume i944,1331,127,460
Last Close$47.54$88.33
52 Week Range$36.28 - $66.00$54.56 - $114.68
% from 52W High-27.97%-22.98%
All-Time High$208.48 (Feb 07, 2022)$114.68 (Nov 04, 2024)
% from All-Time High-77.20%-22.98%
Growth Metrics
Quarterly Revenue Growth0.04%-0.05%
Quarterly Earnings Growth4.30%-0.20%
Financial Health
Profit Margin (TTM) i0.03%0.04%
Operating Margin (TTM) i0.06%0.06%
Return on Equity (TTM) i0.07%0.12%
Debt to Equity (MRQ) i111.1356.60
Cash & Liquidity
Book Value per Share (MRQ)$69.83$23.56
Cash per Share (MRQ)$5.63$3.85
Operating Cash Flow (TTM) i$648.78M$573.81M
Levered Free Cash Flow (TTM) i$3.74B$379.45M
Dividends
Last 12-Month Dividend Yield i3.51%N/A
Last 12-Month Dividend i$1.68N/A

Valuation & Enterprise Metrics Analysis: Concentrix vs Parsons

MetricCNXCPSN
Price Ratios
P/E Ratio (TTM) i10.2239.23
Forward P/E i3.9222.49
PEG Ratio i0.02-1.96
Price to Sales (TTM) i0.311.40
Price to Book (MRQ) i0.693.71
Market Capitalization
Market Capitalization i$3.10B$9.34B
Enterprise Value i$7.48B$10.52B
Enterprise Value Metrics
Enterprise to Revenue i0.771.57
Enterprise to EBITDA i5.2619.47
Risk & Other Metrics
Beta i0.550.64
Book Value per Share (MRQ) i$69.83$23.56

Financial Statements Comparison: Concentrix vs Parsons

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CNXCPSN
Revenue/Sales i$2.37B$1.58B
Cost of Goods Sold i$1.52B$1.24B
Gross Profit i$855.90M$348.35M
Research & Development iN/AN/A
Operating Income (EBIT) i$168.87M$96.30M
EBITDA i$334.50M$130.34M
Pre-Tax Income i$100.79M$89.18M
Income Tax i$30.54M$18.69M
Net Income (Profit) i$70.26M$70.49M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CNXCPSN
Cash & Equivalents i$308.00M$269.75M
Total Current Assets i$2.96B$2.40B
Total Current Liabilities i$1.79B$1.87B
Long-Term Debt i$4.90B$893.53M
Total Shareholders Equity i$4.03B$2.55B
Retained Earnings i$1.24B$487.63M
Property, Plant & Equipment i$0$269.27M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CNXCPSN
Operating Cash Flow i$231.10M$125.40M
Capital Expenditures i$-55.79M$0
Free Cash Flow i$180.74M$-25.26M
Debt Repayment i$-1.45B$-174.38M
Common Stock Repurchase i$-46.82M$-25.00M

Short Interest & Institutional Ownership Analysis

MetricCNXCPSN
Shares Short i7.66M6.28M
Short Ratio i12.276.89
Short % of Float i0.15%0.12%
Average Daily Volume (10 Day) i1,434,8801,034,329
Average Daily Volume (90 Day) i944,1331,127,460
Shares Outstanding i64.24M106.78M
Float Shares i35.03M53.70M
% Held by Insiders i0.16%0.01%
% Held by Institutions i0.98%1.06%

Dividend Analysis & Yield Comparison: Concentrix vs Parsons

MetricCNXCPSN
Last 12-Month Dividend i$1.68N/A
Last 12-Month Dividend Yield i3.51%N/A
3-Year Avg Annual Dividend i$1.33N/A
3-Year Avg Dividend Yield i0.49%N/A
3-Year Total Dividends i$4.00N/A
Ex-Dividend DateOct 24, 2025N/A